Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celso Arango

Showing results (91-100 of 570) with videos related to

Pageof 57
Sort By:
Brain Sciences|August 6, 2021
Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum DisorderSpyridon Siafis, Alessandro Rodolico, Oğulcan Çıray, et al.
Schizophrenia Research|June 14, 2016
Treatment of negative symptoms: Where do we stand, and where do we go?André Aleman, Tania M Lincoln, Richard Bruggeman, et al.
Frontiers in Psychiatry|February 27, 2019
Mobile App-Based Intervention for Adolescents With First-Episode Psychosis: Study Protocol for a Pilot Randomized Controlled TrialSara Barbeito, Teresa Sánchez-Gutiérrez, María Mayoral, et al.
The Journal of Clinical Psychiatry|January 17, 2012
Increased risk of diabetes mellitus among persons with psychotic symptoms: results from the WHO World Health SurveyRoberto Nuevo, Somnath Chatterji, David Fraguas, et al.
The Lancet. Psychiatry|December 3, 2021
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and EuropeDragana Bugarski-Kirola, Celso Arango, Maurizio Fava, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 18, 2021
Preventive psychiatry: a blueprint for improving the mental health of young peoplePaolo Fusar-Poli, Christoph U Correll, Celso Arango, et al.
Neuropsychiatric Disease and Treatment|June 24, 2024
Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice GuidelineChristoph U Correll, Celso Arango, Andrea Fagiolini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2022
Is there such a thing as gambling dual disorder? Preliminary evidence and clinical profilesNéstor Szerman, Ignacio Basurte-Villamor, Pablo Vega, et al.
Frontiers in Psychiatry|December 17, 2020
Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience PerspectiveNestor Szerman, Francisco Ferre, Ignacio Basurte-Villamor, et al.
Journal of Autism and Developmental Disorders|April 2, 2011
Estimation of the intelligence quotient using Wechsler Intelligence Scales in children and adolescents with Asperger syndromeJessica Merchán-Naranjo, María Mayoral, Marta Rapado-Castro, et al.
Pageof 57

Showing results (91-100 of 570) with videos related to

Sort By:
Pageof 57
Brain Sciences|August 6, 2021
Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum DisorderSpyridon Siafis, Alessandro Rodolico, Oğulcan Çıray, et al.
Schizophrenia Research|June 14, 2016
Treatment of negative symptoms: Where do we stand, and where do we go?André Aleman, Tania M Lincoln, Richard Bruggeman, et al.
Frontiers in Psychiatry|February 27, 2019
Mobile App-Based Intervention for Adolescents With First-Episode Psychosis: Study Protocol for a Pilot Randomized Controlled TrialSara Barbeito, Teresa Sánchez-Gutiérrez, María Mayoral, et al.
The Journal of Clinical Psychiatry|January 17, 2012
Increased risk of diabetes mellitus among persons with psychotic symptoms: results from the WHO World Health SurveyRoberto Nuevo, Somnath Chatterji, David Fraguas, et al.
The Lancet. Psychiatry|December 3, 2021
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and EuropeDragana Bugarski-Kirola, Celso Arango, Maurizio Fava, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 18, 2021
Preventive psychiatry: a blueprint for improving the mental health of young peoplePaolo Fusar-Poli, Christoph U Correll, Celso Arango, et al.
Neuropsychiatric Disease and Treatment|June 24, 2024
Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice GuidelineChristoph U Correll, Celso Arango, Andrea Fagiolini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2022
Is there such a thing as gambling dual disorder? Preliminary evidence and clinical profilesNéstor Szerman, Ignacio Basurte-Villamor, Pablo Vega, et al.
Frontiers in Psychiatry|December 17, 2020
Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience PerspectiveNestor Szerman, Francisco Ferre, Ignacio Basurte-Villamor, et al.
Journal of Autism and Developmental Disorders|April 2, 2011
Estimation of the intelligence quotient using Wechsler Intelligence Scales in children and adolescents with Asperger syndromeJessica Merchán-Naranjo, María Mayoral, Marta Rapado-Castro, et al.
Pageof 57